Brain Cancer Therapeutics Market
- 2026 年市場規模
- USD 4,052 Mn
- 2033 年預估規模
- USD 7,796.3 Mn
- 年複合成長率 CAGR
- 9.8%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Brain Cancer Therapeutics Market, By Indication (Glioblastoma, Meningioma, Pituitary Tumors, Others), By Treatment Type (Targeted Therapy, Chemotherapy, Immunotherapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
Cancer is one of the most prevalent and fatal chronic disorders with a high mortality rate. Throughout our lives, healthy cells in our bodies divide and replace themselves in a controlled fashion. Cancer starts when a cell is altered and it multiplies out of control. A tumor is formed when such abnormal cells grow to form a mass. Cancer cells grow to form tumor that interfere with brain functions such as muscle control, memory, sensation, and other normal bodily functions. Symptoms of brain cancer vary but often include weakness, difficulty walking, dizziness, seizures, and headaches.
The brain and spinal column make up the central nervous system (CNS), where all important functions are controlled. These functions include thought, body movements, and speech. This means that when a tumor grows in the CNS, it can affect a person's thought processes or the way they move or talk. A treatment plan is individualized and planned for each brain cancer patient depending on certain factors. The treatment plan is constructed by the doctors who are specialized in brain cancer, and treatments vary widely depending on the type of cancer, brain location of the tumor, tumor size, patient age, and the general health status of the patient. A major part of the plan is also determined by the wish of the patient.
Market Dynamics
The increasing launches of new drugs and regulatory approvals for brain cancer therapeutics are expected to drive the market growth during the forecast period. For instance, in June 2020, Food and Drug Administration (FDA) has granted fast track designation to TVAX Biomedical, Inc. for TVI-Brain-1, an adoptive T cell therapy for the treatment of glioblastoma multiforme. TVI-Brain-1 (TVAX Biomedical) is an autologous, vaccine-enhanced adoptive T-cell therapy consisting a proprietary vaccine pretreatment to create cancer-specific T cells and an activated antitumor T-cell treatment. The Fast Track Designation was supported by positive Phase 2 clinical data in addition to extensive preclinical and Phase 1 safety studies.
Key features of the study
• This report provides an in-depth analysis of the global brain cancer therapeutics market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global brain cancer therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Amgen Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Pfizer Inc., GlaxoSmithKline PLC, Novartis AG, Johnson & Johnson, Merck & Co, Bayer AG, and Bristol-Myers Squibb Company
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global brain cancer therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global brain cancer therapeutics market
Market Segmentation
• By Indication Insights (Revenue, USD Mn, 2021 - 2033)
o Glioblastoma
o Meningioma
o Pituitary Tumors
o Others
• By Treatment Type Insights (Revenue, USD Mn, 2021 - 2033)
o Targeted Therapy
o Chemotherapy
o Immunotherapy
o Others
• By Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
North Africa
Central Africa
South Africa
• Key Players in the Brain Cancer Therapeutics Market
o Amgen Inc.
o AstraZeneca PLC
o Hoffmann-La Roche Ltd
o Pfizer Inc.
o GlaxoSmithKline PLC
o Novartis AG
o Johnson & Johnson
o Merck & Co
o Bayer AG
o Bristol-Myers Squibb Company
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Indication
Market Snapshot, By Treatment Type
Market Snapshot, Distribution Channel
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Opportunity
o Impact Analysis
o Pipeline Analysis
o Regulatory Scenario
o Market Trends
o Key Developments
o Epidemiology
o PEST Analysis
o Brand Analysis
4. Global Brain Cancer Therapeutics Market, By Indication, 2021 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Glioblastoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Meningioma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Pituitary Tumors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
5. Global Brain Cancer Therapeutics Market, By Treatment Type, 2021 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Targeted Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Million)
o Chemotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Million)
o Immunotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Million)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
6. Global Brain Cancer Therapeutics Market, By Distribution Channel, 2021 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Million)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Million)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Million)
7. Global Brain Cancer Therapeutics Market, By Region, 2021 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 – 2033, (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 – 2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 – 2033, (USD Mn)
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 – 2033, (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 – 2033, (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Region/Countries, 2021 – 2033, (USD Mn)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
Amgen Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
AstraZeneca PLC
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Hoffmann-La Roche Ltd.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Pfizer Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
GlaxoSmithKline PLC
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Novartis AG
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Johnson & Johnson
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Merck & Co
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Bayer AG
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Bristol-Myers Squibb Company
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
o Analyst Views
9. Section
o Research Methodology
o About us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們